首页> 外国专利> Anti-Proliferative Btg2 (B-cell Translocation Gene 2) Protein Regulating Mitochondrial Activities and the Use Thereof

Anti-Proliferative Btg2 (B-cell Translocation Gene 2) Protein Regulating Mitochondrial Activities and the Use Thereof

机译:调节线粒体活性的抗增殖Btg2(B细胞易位基因2)蛋白及其用途

摘要

The present invention relates to a novel cell proliferation inhibiting composition using Btg2, which comprises a cell proliferation inhibitor comprising a gene carrier comprising a nucleic acid molecule of the first sequence of the sequence listing targeted to the mitochondria by the nucleic acid molecule of the second sequence of the sequence listing, / RTI We found that Btg2, also known as the nuclear protein, is also present in mitochondria, and Btg2 targeted to mitochondria by a particular sequence (SEQ ID No. 2 of the present invention) And decreased production of ATP and increased production of reactive oxygen species (ROS). The present inventors intend to propose a possibility of inhibiting Btg2-dependent cancer cell proliferation by providing a cell proliferation inhibitory effect using the composition of the present invention. In particular, the present inventors intend to propose an anticancer effect in ovarian cancer or cervical cancer and a more advanced anti-cancer effect by gonadotropin Effect.
机译:本发明涉及使用Btg2的新型细胞增殖抑制组合物,其包含细胞增殖抑制剂,所述细胞增殖抑制剂包含基因载体,所述基因载体包含通过第二序列的核酸分子靶向线粒体的序列表的第一序列的核酸分子。在序列表中,我们发现线粒体中也存在Btg2,也称为核蛋白,并且通过特定序列(本发明的SEQ ID No.2)靶向线粒体的Btg2和产量降低ATP和增加活性氧(ROS)的产生。本发明人打算提出通过使用本发明的组合物提供细胞增殖抑制作用来抑制Btg2依赖性癌细胞增殖的可能性。特别地,本发明人打算提出在卵巢癌或子宫颈癌中的抗癌作用以及通过促性腺激素效应的更高级的抗癌作用。

著录项

  • 公开/公告号KR101469247B1

    专利类型

  • 公开/公告日2014-12-09

    原文格式PDF

  • 申请/专利权人

    申请/专利号KR20120122671

  • 发明设计人 전상영;박재일;

    申请日2012-10-31

  • 分类号A61K48;A61K47/48;A61P35;

  • 国家 KR

  • 入库时间 2022-08-21 15:01:09

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号